Guest guest Posted December 12, 2008 Report Posted December 12, 2008 Ofatumumab Demonstrates Clinical Benefit in Heavily Pretreated Patients With Refractory CLL Who Have No Standard Treatment Options Capsule summary with tables and charts available at http://www.clinicaloptions.com/Oncology/Conference%20Coverage/Hematology%202008/\ Tracks/CLL%20and%20CML/Capsules/328.aspx Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.